Marianna Frascarelli

Marianna Frascarelli

Auto-generated profile, based on publicly available information

Marianna Frascarelli

Department of Human Neurosciences, Sapienza University, Rome, Italy

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2016 in Journal of Affective Disorders
Verified
Journal Article
Open access
Grazia RutiglianoGrazia Rutigliano
Grazia Rutigliano
LVLucia Valmaggia
Lucia Valmaggia
PLPaola Landi
Paola Landi
MFMarianna Frascarelli
Marianna Frascarelli
MCMarco Cappucciati
Marco Cappucciati
PFPaolo Fusar-Poli
Paolo Fusar-Poli
Patients at ultra-high risk for psychosis (UHR) are a highly heterogeneous group in terms of clinical and functional outcomes. Several non-psychotic mental disorders co-occur together with the UHR state. Little is known about the impact of non-psychotic comorbid mental disorders on clinical and functional outcomes of UHR patients. The sample included 154 UHR help-seeking patients (identified with the CAARMS, comprehensive assessment of the at-risk mental state), evaluated at baseline on the Ham-D, Ham-A (Hamilton depression/anxiety rating scale), and PANSS (positive and negative syndrome scale). 74 patients completed the 6-year follow-up assessment (mean=6.19, SD=1.87). Comorbid disorders at follow-up were assessed with the SCID I and II. Global functioning was rated on the global assessment of functioning (GAF) scale. In the present sample, 6-year risk of psychosis transition was 28.4%. Among non-transitioned UHR patients, 28.3% reported attenuated psychotic symptoms (APS) and 45.3% remained functionally impaired at follow-up (GAF<60). 56.8% patients were affected by at least one comorbid disorder at follow-up. Among UHR patients who presented with some comorbid disorder at baseline, 61.5% had persistent or recurrent course. Incident comorbid disorders emerged in 45.4% of baseline UHR patients. The persistence or recurrence of non-psychotic comorbid mental disorders was associated with poorer global functional outcomes at follow-up. A substantial proportion of the initial sample was not available for follow-up interviews and some groups in the analyses had small sample size. Predictors of longitudinal outcomes were not explored. Among UHR patients, persistence or recurrence of non-psychotic comorbid mental disorders, mostly affective disorders, is associated with 6-year poor functional outcomes.

1 August 2015 in Psychiatry Research
Verified
Journal Article
Closed access
IFIrina Falkenberg
Irina Falkenberg
LVLucia Valmaggia
Lucia Valmaggia
MBMajella Byrnes
Majella Byrnes
MFMarianna Frascarelli
Marianna Frascarelli
CJCeri Jones
Ceri Jones
PFPaolo Fusar-Poli
Paolo Fusar-Poli

9 June 2014 in Psychiatry and Clinical Neurosciences
Verified
Journal Article
Closed access
PDF file
MRMatteo Rocchetti
Matteo Rocchetti
Joaquim RaduàJoaquim Raduà
Joaquim Raduà
YPYannis Paloyelis
Yannis Paloyelis
LXLida‐Alkisti Xenaki
Lida‐Alkisti Xenaki
MFMarianna Frascarelli
Marianna Frascarelli
PFPaolo Fusar-Poli
Paolo Fusar-Poli

22 October 2014 in Psychological Medicine
Verified
Journal Article
Closed access
PDF file
PFPaolo Fusar-Poli
Paolo Fusar-Poli
MFM. Frascarelli
M. Frascarelli
LVL. Valmaggia
L. Valmaggia
MBM. Byrne
M. Byrne
DSDaniel Richard Stahl
Daniel Richard Stahl
PMP. McGuire
P. McGuire
Background.: Recent randomized controlled trials suggest some efficacy for focused interventions in subjects at high risk (HR) for psychosis. However, treating HR subjects within the real-world setting of prodromal services is hindered by several practical problems that can significantly make an impact on the effect of focused interventions.Method.: All subjects referred to Outreach and Support in South London (OASIS) and diagnosed with a HR state in the period 2001–2012 were included (n = 258). Exposure to focused interventions was correlated with sociodemographic and clinical characteristics at baseline. Their association with longitudinal clinical and functional outcomes was addressed at follow-up.Results.: In a mean follow-up time of 6 years (s.d. = 2.5 years) a transition risk of 18% was observed. Of the sample, 33% were treated with cognitive behavioural therapy (CBT) only; 17% of subjects received antipsychotics (APs) in addition to CBT sessions. Another 17% of subjects were prescribed with antidepressants (ADs) in addition to CBT. Of the sample, 20% were exposed to a combination of interventions. Focused interventions had a significant relationship with transition to psychosis. The CBT + AD intervention was associated with a reduced risk of transition to psychosis, as compared with the CBT + AP intervention (hazards ratio = 0.129, 95% confidence interval 0.030–0.565, p = 0.007).Conclusions.: There were differential associations with transition outcome for AD v. AP interventions in addition to CBT in HR subjects. These effects were not secondary to baseline differences in symptom severity.

7 October 2013 in Human Brain Mapping
Verified
Journal Article
Open access
PDF file
PFPaolo Fusar-Poli
Paolo Fusar-Poli
Joaquim RaduàJoaquim Raduà
Joaquim Raduà
MFMarianna Frascarelli
Marianna Frascarelli
AMAndrea Mechelli
Andrea Mechelli
SBStefan Borgwardt
Stefan Borgwardt
Sean DavidSean David
Sean David
Objectives To evaluate whether biases may influence the findings of whole-brain structural imaging literature. Methods Forty-seven whole-brain voxel-based meta-analyses including voxel-based morphometry (VBM) studies in neuropsychiatric conditions were included, for a total of 324 individual VBM studies. The total sample size, the overall number of foci, and different moderators were extracted both at the level of the individual studies and at the level of the meta-analyses. Results Sample size ranged from 12 to 545 (median n = 47) per VBM study. The median number of reported foci per study was six. VBM studies with larger sample sizes reported only slightly more abnormalities than smaller studies (2% increase in the number of foci per 10-patients increase in sample size). A similar pattern was seen in several analyses according to different moderator variables with some possible modulating evidence for the statistical threshold employed, publication year and number of coauthors. Whole-brain meta-analyses (median sample size n = 534) found fewer foci (median = 3) than single studies and overall they showed no significant increase in the number of foci with increasing sample size. Meta-analyses with ≥10 VBM studies reported a median of three foci and showed a significant increase with increasing sample size, while there was no relationship between sample size and number of foci (median = 5) in meta-analyses with <10 VBM studies. Conclusions The number of foci reported in small VBM studies and even in meta-analyses with few studies may often be inflated. This picture is consistent with reporting biases affecting small studies. Hum Brain Mapp 35:3052–3065, 2014.

29 March 2017 in Brain Imaging and Behavior
Verified
Journal Article
Closed access
PDF file
FPFabrizio Parente
Fabrizio Parente
MFMarianna Frascarelli
Marianna Frascarelli
AMAlessia Mirigliani
Alessia Mirigliani
FFFabio Di Fabio
Fabio Di Fabio
MBMassimo Biondi
Massimo Biondi
ACAlfredo Colosimo
Alfredo Colosimo